WallStreetZenWallStreetZen

NASDAQ: CPRX
Catalyst Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Catalyst Pharmaceuticals earnings were $221.3M for the trailing 12 months ending Mar 31, 2026, with 9.7% growth year over year. The latest CPRX earnings report on Mar 31, 2026 announced Q1 2026 earnings of $63.7M, up 20.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CPRX reported annual earnings of $214.3M, with 30.8% growth.

CPRX past earnings growth

How has CPRX's earnings growth performed historically?

Company
9.7%
Industry
49.08%
Market
83.38%
CPRX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CPRX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CPRX's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CPRX earnings history

Current Revenue
$597.0M
Current Earnings
$221.3M
Current Profit Margin
37.1%

CPRX Return on Equity

Current Company
23.7%
Current Industry
-142%
Current Market
13.5%
CPRX's Return on Equity (23.7%)... subscribe to Premium to read more.
High Return on Equity Performance

CPRX Return on Assets

Current Company
20.7%
Current Industry
-13.7%
CPRX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CPRX announces earnings.

CPRX Return on Capital Employed

Current Company
29.2%
Current Industry
-9.5%
CPRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CPRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CPRX$334.94M$221.32M+21.27%$1.81
MANEN/AN/AN/AN/A
CRNX-$489.18M-$496.39MN/A-$5.13
EWTX-$173.71M-$176.01MN/A-$1.67
DNLI-$492.55M-$508.02MN/A-$2.88
View Top Biotech Stocks

Catalyst Pharmaceuticals Earnings Reports & History FAQ

What were Catalyst Pharmaceuticals's earnings last quarter?

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 2026 earnings per share (EPS) of $0.52, up 10.64% year over year. Total CPRX earnings for the quarter were $63.73 million. In the same quarter last year, Catalyst Pharmaceuticals's earnings per share (EPS) was $0.47.

If you're new to stock investing, here's how to buy Catalyst Pharmaceuticals stock.

Is Catalyst Pharmaceuticals profitable or losing money?

As of the last Catalyst Pharmaceuticals earnings report, Catalyst Pharmaceuticals is currently profitable. Catalyst Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $221.32 million, a 12.15% increase year over year.

What was CPRX's earnings growth in the past year?

As of Catalyst Pharmaceuticals's earnings date in Q2 2026, Catalyst Pharmaceuticals's earnings has grown 9.7% year over year. This is 39.38 percentage points lower than the US Biotechnology industry earnings growth rate of 49.08%. CPRX earnings in the past year totalled $221.32 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.